Change over period: —
NSE · ABBOTINDIA
ABBOTT (I)
-15.7% from the 52-week high · +1.8% above the low
Abbott India Ltd. engages in the development, manufacture, and sale of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 3,700 full-time employees. The firm has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. The company provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolics, multi-specialty, vaccines and consumer health, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremalax (constipation), Pankreoflat (indigestion) and Duvadilan (preterm labor), among others. The company offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure and Glucerna, among others.
The short version. Promoter holding was 74.99% in Jun 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
ABBOTT (I) trades 15.7% below its 52-week high and 1.8% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Up 0.22 pts over 8 quarters.
Down 0.21 pts over 8 quarters.
+36 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 0.0 |
| FII | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.18 | 0.26 | 0.38 | +0.22 |
| DII | 8.99 | 9.01 | 8.92 | 9.19 | 9.11 | 9.0 | 8.93 | 8.78 | -0.21 |
| Public | 15.85 | 15.84 | 15.93 | 15.66 | 15.75 | 15.83 | 15.81 | 15.85 | 0.0 |
Mutual fund holdings · Oct 2026
169 schemes hold this stock
133 the month before.
- TATA INDIA PHARMA & HEALTHCARE FUND5.66% of NAV
- Bank of India Mid Cap Fund4.72% of NAV
- Taurus Mid Cap Fund4.17% of NAV
- UTI BSE Low Volatility Index Fund3.45% of NAV
- Motilal Oswal BSE low Volatility Index Fund3.45% of NAV
- Motilal Oswal BSE Low Volatility ETF3.45% of NAV
- PGIM INDIA HEALTHCARE FUND3.22% of NAV
- NJ ELSS Tax Saver Fund3.22% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for ABBOTT (I) are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about ABBOTT (I)
What is the ABBOTT (I) share price?
ABBOTT (I) (ABBOTINDIA) last closed at ₹25,695.00, up 0.88% on the day. Its 52-week range is ₹25,030.00 to ₹30,205.00.
What is the market cap of ABBOTT (I)?
ABBOTT (I) has a market capitalisation of about ₹54,166 crore. Its price-to-earnings ratio is 32.8.
How are ABBOTT (I)'s latest results?
Promoter holding was 74.99% in Jun 2026, up 0.00 points over 8 quarters.
Who owns ABBOTT (I)?
As of Jun 2026, shareholding was: Promoter 74.99%, FII 0.38%, DII 8.78%, Public 15.85%.
How many mutual funds hold ABBOTT (I)?
169 mutual fund schemes held ABBOTT (I) in October 2026. That compares with 133 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 25 Jul 2025 · Final Dividend - Rs. 475
- 19 Jul 2024 · Final Dividend - Rs. 410
- 21 Jul 2023 · Final Dividend - Rs. 180
- 21 Jul 2023 · Special Dividend - Rs. 145
- 02 Aug 2022 · Special Dividend - Rs. 130
- 02 Aug 2022 · Final Dividend - Rs. 145
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.